March 1, 2024 · Form 4 insider transaction
BEHRENS M KATHLEEN bought 3,679 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.